Podcasts about neffy

A new epinephrine nasal spray dosage has been approved for pediatrics; FDA agree to review Semaglutide for weight management; A wearable defibrillator is cleared to prevent sudden cardiac arrest; a low dose formulation of chlorthalidone is approved to treat hypertension; and Selarsdi is now interchangeable with Stelara.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Industry is anxiously awaiting the hearing for FDA commissioner nominee Marty Makary, following disruptions and layoffs at the FDA. Novo Nordisk and Eli Lilly are intervening in legal battles against drug compounders over shortages of glp-1 compounds. ARS Pharmaceuticals has received FDA approval for Neffy spray for children with anaphylaxis. A Pitchbook report found $4.3 billion in funding for women-led biotech companies amid sociopolitical headwinds affecting initiatives to support women and minorities.Tariff threats, Novo launching a DTC program for WeGovy, Merck's legal dispute over injectable Keytruda plans, and Jazz's acquisition of Chimerix are also making headlines. The job market outlook is still uncertain, with layoffs cooling off but rare disease biotechs struggling as Congress fails to renew priority review programs. Various job opportunities in the biotech industry are also listed.

Labeling changes for testosterone products; food allergy treatments compared; FDA approves stroke Tx; COVID-19, flu vaccine effectiveness for recent season; Neffy 1mg approved

Dr. Phil Jones helps us unwrap the trappings of holiday foods for food allergic patients, specifically those who are allergic to tree nuts. Hazelnuts, walnuts, pistachios...all the nutty flavors added to our favorite holiday helpings can cause pollen-food allergy syndrome for people allergic to certain tree pollens as well as life-threatening symptoms for food-allergic patients. Dr. Jones shares how various food testing strategies can better identify these allergies and how you can be prepared for possible exposure. He also introduces us to the newest alternative to needle epinephrine: Neffy.  

AlabamaAL congressman predicts Hunter Biden will mess up again despite pardonSeveral AL congressmen react to Joe Biden's "hypocrisy & lies " on pardonSen. Tuberville met with 2 Trump nominees on MondayFDA has approved "Neffy" nasal spray as alternative to an epi-penDowntown Dothan to hold North Pole Stroll & Holiday Festival this weekendArtic air from the North Pole to continue until Friday, weekend warmerNationalSpecial counsel David Weiss disputes claims that Hunter Biden was targetedIRS whistleblowers point out Hunter Biden entered guilty plea to tax evasionSCOTUS to hear TN case regarding transgender treatment for minorsCA pastor detains church burglar on Thanksgiving day using his martial artsClosing statements made in NYC case against Daniel Penny and chokeholdHouse subcommittee releases report that justifies Covid conspiracy theorists

Exploring Neffy Nasal Spray: A Needle-Free Epinephrine Option Managing anaphylaxis just became easier with Neffy, the FDA-approved nasal spray for epinephrine. This innovative, needle-free option is transforming emergency allergy care. Dr. Autumn Burnette joins Dr. Payel Gupta and Kortney to discuss how Neffy works, who it's best suited for, and its potential impact on anaphylaxis treatment. With her expertise in allergy and immunology, Dr. Burnette addresses common concerns about Neffy's effectiveness, highlights its benefits, and shares practical details like cost, shelf life, and heat sensitivity. What We Cover in our Episode About Neffy Nasal Spray Delivery System A Game-Changer for Anaphylaxis: Discover how Neffy offers a needle-free option for delivering life-saving epinephrine during severe allergic reactions. Patient Benefits of Neffy: Learn how its ease of use and accessibility can make anaphylaxis management less daunting for patients. Addressing Skepticism About Neffy: Dr. Burnette explains how studies validate Neffy's effectiveness and addresses questions about trusting a nasal spray for emergencies. Practical Tips for Neffy Use: Get insights on cost, insurance coverage, shelf life, and whether Neffy works with nasal congestion or nose jobs! Expanding Treatment Options: Explore why having more options like Neffy is exciting for patients and healthcare providers alike. More resources about Anaphylaxis and Neffy:  Neffy: https://www.neffy.com/ Anaphylaxis: https://allergyasthmanetwork.org/anaphylaxis/ Epinephrine: https://allergyasthmanetwork.org/anaphylaxis/what-is-epinephrine/ Made in partnership with The Allergy & Asthma Network. Thanks to ARS Pharma for sponsoring today's episode. While they support the show, all opinions are our own, and sponsorship doesn't influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement. This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.  

This interview first aired on Friday the 15th of November, 2024 on ONE FM 98.5 Shepparton. One FM breakfast announcer Plemo interviews Steve 'Neffy' Neff about the voluntary support group We Listen and the upcoming charity raffle at the Shepparton Club which will donate the proceeds to We Listen. We Listen meets on the second Wednesday of every month at the North Shepparton Community and Learning Centre, Parkside Drive, Shepparton at 6pm For more information you can call Neffy on 0400 314 858. Listen to Plemo live on weekday mornings from 6am-9am. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

Curious About Neffy, the New Nasal Epinephrine Spray? We're diving into everything you need to know about Neffy, the new FDA-approved nasal spray for epinephrine. This groundbreaking, needle-free option provides an easy way to manage anaphylaxis in emergencies. Dr. Sakina Bajowala joins Dr. Gupta and Kortney to explore Neffy's unique nasal delivery system, what distinguishes it from traditional auto-injectors, and the science behind its development. With her expertise in allergy and asthma care, Dr. Bajowala walks us through Neffy's FDA approval journey, the technology that powers the nasal spray, and how it's changing the landscape of allergy treatment. What We Cover in Our Episode on Neffy Nasal Spray: Why Neffy Nasal Spray is Unique: Dr. Bajowala explains why nasal epinephrine is an innovative choice for anaphylaxis treatment and when it may be preferable to injectables. FDA Approval for Neffy: We discuss the rigorous testing behind Neffy's FDA approval, including studies conducted with actual patients post-approval. Intravail Technology in Neffy Nasal Spray: Learn about the advanced technology enabling rapid, effective absorption through the nasal passages for timely intervention. Considerations for Using Neffy Nasal Spray: We explore practical aspects of Neffy's use, from nasal congestion to potential side effects. Neffy Dosing and Side Effects: Dr. Bajowala provides insights on dosing, including when a second dose may be recommended. Helpful links: Neffy: https://www.neffy.com/ Anaphylaxis: https://allergyasthmanetwork.org/anaphylaxis/ Epinephrine: https://allergyasthmanetwork.org/anaphylaxis/what-is-epinephrine/ This podcast is made in partnership with The Allergy & Asthma Network. Thanks to ARS Pharma for sponsoring today's episode. While they support the show, all opinions are our own, and sponsorship doesn't influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement.

Nick and Josh hear from Neffy, Director of the We Listen charity - and organiser of Shepparton's Suicide Awareness walk - on, this Saturday the 26th of October. Steven Threlfall, candidate for McEwen, tells us why he should represent you, plus Michael Van Dorsser talks cricket and Ash brings her entertainment guide.See omnystudio.com/listener for privacy information.

Richard Lowenthal, co-founder, and CEO of ARS Pharma, highlights the crucial unmet need for needle-free injections. Challenging issues posed by current epinephrine injectors, In Vivo questions the current and future progression of Neffy.

Broadcast on KSQD, Santa Cruz on 9-26-2024: Dr. Dawn discusses a study on mice whose abdomens were made transparent using tartrazine aka yellow dye #3, explaining the physics behind this phenomenon and potential medical applications. The FDA's approval of an new and cheaper epinephrine nasal spray called Neffy is announced as a more convenient alternative to EpiPens. Hyperaldosteronism, a potentially underdiagnosed condition causing treatment - resistant hypertension in many patients, is explained along with its symptoms and testing methods. A study suggesting that COVID lockdowns may have prematurely aged teenagers' brains is discussed, with notable differences in brain scans of areas affected between boys and girls. Research on racial disparities in unscheduled emergency C-sections among black and white women is examined, considering various factors that might contribute to this difference. Dr. Dawn reviews a meta-analysis on the risks of screening colonoscopies, highlighting higher complication rates than previously thought. The show explores exciting new research on breast milk components and their potential therapeutic applications for various conditions in adult. Recent findings on human aging patterns are presented, revealing two significant aging points in life and discussing how different body systems age at varying rates.

U.S. health officials approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration (FDA) said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis. Anaphylaxis occurs when the body's immune system develops a sudden, unexpected reaction to a foreign substance, such as food, insect stings or medications. Common symptoms include hives, swelling, itching, vomiting and difficulty breathing. The device, marketed as Neffy, could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers. Anaphylaxis sends more than 30,000 people to emergency rooms and results in more than 2,000 hospitalizations and more than 230 deaths in the U.S. each year. Of the 6 million prescriptions written for auto-injectors each year, more than 40% are never filled, Dr. Thomas Casale, an allergist at the University of South Florida, told an FDA advisory panel last year. Even when they are available to caregivers, many auto-injectors are used incorrectly, he said. "There's a real unmet medical need for a large portion of the population," he said. Neffy is intended for people who weigh at least 66 pounds. It is given in a single dose sprayed into one nostril. A second dose can be given if the person's symptoms don't improve. The new treatment could be life-changing for people with severe food allergies, said Dr. Kelly Cleary, a pediatrician and director at the Food Allergy Research & Education, a nonprofit advocacy group. Requiring an injection in an emergency is as scary to some children as the allergic reaction itself. Some parents have had to restrain thrashing children to inject them, sometimes causing cuts that require stitches. About 3,500 caregivers a year are injured when they accidentally inject themselves in the hands, ARS said. Neffy is designed to be easy to carry and easy to use, especially for children, said Richard Lowenthal, president and chief executive of San Diego-based ARS. "We don't want fear. There's no needle, there's no pain with this product," he said. "It's basically like spraying saline into your nose." This article was provided by The Associated Press.

President Biden sat down with CBS News chief election and campaign correspondent Robert Costa for his first interview since exiting the 2024 presidential race three weeks ago and spoke about what prompted him to make the decision to walk away.On Friday, the FDA approved Neffy, the first nasal spray to be used as an emergency treatment for the tens of millions of Americans at risk of potentially life-threatening allergic reactions. CBS News medical contributor Dr. Celine Gounder explains what to know about the new needle-free alternative to the EpiPen.USA Gymnastics is appealing the International Olympic Committee's decision to strip American Jordan Chiles of the bronze medal she won for her floor routine. It comes after an earlier review elevated her in the standings last week.In part two of our feature story on Rhode Island's Judge Frank Caprio, who is renowned for his compassion in court, CBS News contributor David Begnaud shares more from his interview with the judge as he reflects on his recent diagnosis with pancreatic cancer, the lessons he's learned from the bench, and the messages of support from fans that are bringing him new hope in his recovery.Billionaire Michael Rubin is the founder and CEO of Fanatics. The global sports company has three businesses: sports commerce, collectibles and betting. Rubin talks about its first-of-its-kind immersive sports festival in New York City that features an expansive showroom floor of collectibles and memorabilia, and autograph and photo opportunities.Ashley Graham, a supermodel, entrepreneur and investor, and Emma Grede, cofounder and CEO of the clothing brand Good American, and a founding partner of Kim Kardashian's Skims, talks about season two of their series, "Side Hustlers." The show follows a group of women who are competing to receive a cash investment and mentorship to transform their side hustles into big business.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Remember when nights out were filled with disco beats, larger-than-life bouncers, and kebab runs at 3 am? Take a trip down memory lane with us as Cleo and I reminisce about the unforgettable nightlife of the northern beaches in the 80s and 90s. From the legendary Rock Lily to the bustling Figure 5 and the lively Cartoons in DY, we recount our wildest nights and the iconic spots that defined our youth. What's happened to those cool bouncers we all had crushes on? Cleo has some hilarious theories that will leave you in stitches.We also chat about the late-night munchies that followed every epic night out. Ever lined up at Neffy's or the famous Caravan of Courage on Pittwater Road? We have, and we're sharing our funniest food escapades. And who could forget the legendary dollar drinks at the Jet Club in DY? With tales of struggling to catch a taxi during the dreaded 3 am changeover, this episode is a heartwarming and humorous celebration of a bygone era that shaped our younger years. Join us for a laugh-filled, nostalgic journey that will have you yearning for those simpler, wilder times.

In this episode, we are joined by Monalissa, Fatima, and Neffy where they discuss health disparities. They even offer possible solutions to improve areas where there are high levels of health disparities.

This interview first aired on Thursday the 22nd of February, 2024 on ONE FM 98.5 Shepparton. One FM fill-in breakfast announcer Plemo interviews David Savige from the Ardmona Football Netball Club's upcoming Show N' Shine car show. Ardmona Football Netball Club's Show N' Shine car show will be held on Saturday the 24th of February, 2024 at the Ardmona Recreation Reserve. 50% of funds raised on the day will be donated to Neffy's Talk! - suicide support group. Listen to One FM Breakfast live on weekday mornings from 6am-9am. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

This interview first aired on Thursday the 17th of November, 2023 on ONE FM 98.5 Shepparton. One FM fill-in breakfast announcer Plemo interviews Steve 'Neffy' Neff and Mitchell who are holding Neffy's Walk - Let's Talk! to remember those lost to suicide and to raise awareness of suicide prevention. Suicide Prevention Awareness Walk Memorial Candlelight walk in memory of loved ones lost to suicide. All welcome to attend, donate or purchase a candle in memory of those lost to suicide. All proceeds to go to Lifeline. It's on at 4pm Saturday the 18th of November, 2023) at Victoria Park Lake. For more information head to https://www.facebook.com/events/806929533907913 Listen to Terri Cowley live on weekday mornings from 6am-9am. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

New York rapper Hollywood talks growing up in the system, his new found success, funny stories & more.Tap in!

Recently, the food allergy community anxiously awaited good news of FDA approval for neffy® (needle-free nasal epinephrine spray), but to the community's shock, the FDA denied approval. ARS Pharma Co-founder, President and CEO, Richard Lowenthal, joins us to explain what happened and where neffy® stands. Resources to keep you in the know:ARS PharmaStay tuned and follow FAACT to learn how you can take action and personally advocate for the approval of neffy® with your local and federal legislators. You can find the FAACT Roundtable Podcast on Pandora, Apple Podcast, Spotify, Google Podcast, Stitcher, iHeart Radio, Podcast Chaser, Deezer, and Listen Notes.Visit us at www.FoodAllergyAwareness.org.Sponsored by: ARS PharmaThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

In this week's New FDA Approval's podcast episode, Dr. Emma Hitt Nichols discusses the latest FDA approvals from September 18, 2023 – September 22, 2023.  Please check back every Monday morning so that you can stay up to date.  Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With Your Medical Writer – 8 Ways to Get the Most out of Them See more details summaries and links to prescribing information at nascentmc.com/podcast Here are the highlights: Jardiance (empagliflozin) for CKD  The FDA has approved Jardiance, an SGLT2 inhibitor, for patients with end-stage kidney disease, speciifically to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression. The approval is based on the EMPA-KIDNEY phase 3 trial, demonstrating a significant reduction in kidney disease progression and cardiovascular death compared to a placebo.  Welireg (belzutifan) for Advanced Renal Cell Carcinoma The FDA granted Priority Review for Merck's Welireg for advanced renal cell carcinoma post other treatments. Welireg, a HIF-2α inhibitor, is being evaluated in the LITESPARK-005 trial, where it was compared with everolimus for advanced RCC treatment post PD-1/L1 or VEGF-TKI therapies. Tevimbra (tislelizumab) for Esophageal Squamous Cell Carcinoma The FDA is reviewing an application for Tevimbra for treating advanced or metastatic esophageal squamous cell carcinoma. Supported by the phase 3 RATIONALE 306 study, the drug improves overall survival rates when combined with chemotherapy in these patients. Neffy Epinephrine Nasal Spray The FDA rejected the approval of Neffy, a needle-free nasal spray for allergic reactions. Despite a positive Advisory Committee vote, the FDA demands further testing. ARS Pharmaceuticals plans to re-submit its application and appeal the decision in 2024.  Intro and outro music Garden Of Love by Pk jazz Collective

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Today's episode covers a range of updates in the industry.First, we turn our attention to the commercial hurdles facing RSV vaccines. Public health officials and drugmakers are working to raise awareness of RSV among older adults at risk. They are also encouraging them to get an additional respiratory shot alongside those for COVID-19 and flu. This rollout poses a test for the industry.In a recent House hearing, the pharmacy benefit manager lobby PCMA and drugmaker lobby PhRMA traded blame over problems in the prescription supply chain. They discussed the high costs of drugs and the role that PBMs play in driving up prices. This ongoing debate highlights the challenges within the industry.Moving on, Alvotech has received a new FDA review for its biosimilar of Humira. The regulator had previously rejected Alvotech's copycat drug due to manufacturing issues with a plant in Europe. This new review brings hope for Alvotech's biosimilar.Novartis has canceled its partnership with Beigene as its cancer drug gains EU approval. This decision leaves Novartis without a PD-1 inhibitor, marking a significant development for the company.Orchard is nearing an FDA decision on its rare disease gene therapy, Libmeldy. Three years after gaining European approval, Libmeldy is now under review in the US. This therapy has the potential to make a difference in the lives of patients.Shifting gears, an FDA panel has backed Alnylam's drug Onpattro for cardiomyopathy of ATTR amyloidosis, despite doubts over its benefit. This endorsement provides support for this drug's use in treating this condition.We also have various resources for further reading and upcoming events available. Check out Biopharma Dive and its publications for more information.In another news story, Roche's Genentech has partnered with PeptiDream to develop targeted radioisotopes for certain cancers. This collaboration expands their efforts in radiopharmaceuticals and shows promise for future treatments.Taysha has made the decision to drop its lead gene therapy, TSHA-120, following feedback from the FDA. The agency proposed additional studies that Taysha determined would be too challenging to pursue. Additionally, Taysha's partner, Astellas, has declined to pick up an option for the therapy. These developments mark a setback for Taysha.The FDA has also rejected ARS Pharmaceuticals' Neffy as a nasal spray for allergic reactions. Despite receiving backing from the Pulmonary-Allergy Drugs Advisory Committee, this rejection is a setback for ARS. The nasal spray was seen as an alternative to the EpiPen for severe allergic reactions.In other news, Genentech and PeptiDream have signed a potential $1 billion deal for the development of macrocyclic peptide-radioisotope drug conjugates. This partnership has the potential to advance cancer treatments and improve patient outcomes.Recode Therapeutics has raised $260 million in a series B financing round to advance its mRNA therapies. This funding will support further development in this promising field.The clearance of the Amgen-Horizon merger has been seen as a setback to the FTC's antitrust enforcement plans. The consent agreement between Amgen, Horizon Therapeutics, and the FTC could have significant implications for future merger and acquisition challenges.Lastly, Verisim Life has released an ebook on how artificial intelligence can transform R&D with early-stage translational insights in model-informed drug development. This resource provides valuable information on the potential of AI in drug development.That's all for today's episode. Thank you for tuning in to Pharma and Biotech Daily. Stay informed and stay ahead in the industry.

Rapper Ro Immortal talks future dreams, betting on himself, new music & more. Tap in!

This interview first aired on Thursday the 14th of September, 2023 on ONE FM 98.5 Shepparton. One FM announcer Plemo interviews Jacqui Kiss and Steve 'Neffy' Neff about R U OK? Day and their new voluntary support group for those who have experienced thoughts of suicide and are/or have been grieving the loss of someone to suicide. The group meets every Friday at 6pm at the Mooroopna Education and Activity Centre. (Which is located at 23 Alexandra Street, Mooroopna) For more information you can call Neffy on 0400 314 858. Listen to Plemo live on Thursday afternoons from 3pm-6pm. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

Houston singer Khody Blake talks celeb run-ins, hidden talents, being on the new Soulja Boy tour and more. Tap in!

This interview first aired on Thursday the 24th of August, 2023 on ONE FM 98.5 Shepparton. One FM announcer Plemo interviews Jacqui Kiss and Mitchell about their new voluntary support group for those who have experienced thoughts of suicide and are/or have been grieving the loss of someone to suicide. The first group meeting will take place on Friday the 25th of August at 6pm at the Mooroopna Education and Activity Centre. (Which is located at 23 Alexandra Street, Mooroopna) For more information you can call Neffy on 0400 314 858. Listen to Plemo live on Thursday afternoons from 3pm-6pm. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

This interview first aired on Monday the 21st of August, 2023 on ONE FM 98.5 Shepparton. One FM fill-in breakfast announcer Plemo interviews Steve 'Neffy' Neff and Jacqui Kiss about their new voluntary support group for those who have experienced thoughts of suicide and are/or have been grieving the loss of someone to suicide. The first group meeting will take place on Friday the 25th of August at 6pm at the Mooroopna Education and Activity Centre. (Which is located at 23 Alexandra Street, Mooroopna) For more information you can call Neffy on 0400 314 858. Listen to Terri Cowley live on weekday mornings from 6am-9am. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

This interview first aired on Thursday the 17th of August, 2023 on ONE FM 98.5 Shepparton. One FM breakfast announcer Terri Cowley interviews Steve 'Neffy' Neff and Jacqui Kiss about their new voluntary support group for those who have experienced thoughts of suicide and are/or have been grieving the loss of someone to suicide. The first group meeting will take place on Friday the 25th of August at 6pm at the Mooroopna Education and Activity Centre. (Which is located at 23 Alexandra Street, Mooroopna) For more information you can call Neffy on 0400 314 858. Listen to Terri Cowley live on weekday mornings from 6am-9am. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

Genevieve Gaunt performs this compelling audiobook of a near future pandemic. Host Jo Reed and AudioFile's Alan Minskoff discuss this story of a survivor, Neffy, who is portrayed with a vulnerable and youthful tone. Gaunt's crisp English accent works well with this post-apocalyptic London setting. Neffy and four other 20-something survivors are living in a “biopharm” facility and coming to terms with the ghastly reality outside. An engaging and immersive listen. Read the full review of the audiobook on AudioFile's website. Published by Audible, Inc. Find more audiobook recommendations at audiofilemagazine.com Support for AudioFile's Behind the Mic comes from A Soul of Ash and Blood. #1 New York Times bestselling author Jennifer L. Armentrout revisits Poppy and Casteel's epic love story in the next installment of the Blood and Ash series. Learn more at Audible.com/ASoulOfAshAndBlood Learn more about your ad choices. Visit megaphone.fm/adchoices

This interview first aired on Monday the 1st of May, 2023 on ONE FM 98.5 Shepparton. One FM fill-in breakfast announcer Plemo interviews Steve 'Neffy' Neff and Mitchell who recap Neffy's Walk - Let's Talk! to remember those lost to suicide and to raise awareness of suicide prevention which took place on Saturday the 29th of April, 2023. If you require assistance call Lifeline on 13 11 14. For more information head to https://www.facebook.com/events/806929533907913 Listen to Plemo live on Thursday afternoons from 3pm-6pm. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

This interview first aired on Saturday the 22nd of April, 2023 on ONE FM 98.5 Shepparton. One FM Super Saturday Sports Day Host Mark "The Stats Man Owens interviews Steve 'Neffy' Neff who is holding Neffy's Walk - Let's Talk! to remember those lost to suicide and to raise awareness of suicide prevention and also talks about the GV Giants Veterans Football Club Suicide Prevention Awareness Walk Memorial Candlelight walk in memory of loved ones lost to suicide. All welcome to attend, donate or purchase a candle in memory of those lost to suicide. All proceeds to go to Lifeline. It's on at 4pm, Saturday the 29th of April, 2023 at Victoria Park Lake. For more information head to https://www.facebook.com/events/806929533907913 Listen to Terri Cowley live on weekday mornings from 6am-9am. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

This interview first aired on Friday the 28th of April, 2023 on ONE FM 98.5 Shepparton. One FM fill-in breakfast announcer Plemo interviews Steve 'Neffy' Neff who is holding Neffy's Walk - Let's Talk! to remember those lost to suicide and to raise awareness of suicide prevention. Suicide Prevention Awareness Walk Memorial Candlelight walk in memory of loved ones lost to suicide. All welcome to attend, donate or purchase a candle in memory of those lost to suicide. All proceeds to go to Lifeline. It's on at 4pm tomorrow (Saturday the 29th of April, 2023) at Victoria Park Lake. For more information head to https://www.facebook.com/events/806929533907913 Listen to Terri Cowley live on weekday mornings from 6am-9am. Contact the station on admin@fm985.com.au or (+613) 58313131 The ONE FM 98.5 Community Radio podcast page operates under the license of Goulburn Valley Community Radio Inc. (ONE FM) Number 1385226/1. PRA AMCOS (Australasian Performing Right Association Limited and Australasian Mechanical Copyright Owners Society) that covers Simulcasting and Online content including podcasts with musical content, that we pay every year. This licence number is 1385226/1.

Matt (Matthew) Hughes writes fantasy, space opera, and crime fiction. He has sold twenty-four novels to publishers large and small in the UK, US, and Canada, as well as nearly 100 works of short fiction to professional markets. His latest novels are A God in Chains (Dying Earth fantasy) from Edge Publishing and What the Wind Brings (magical realism/historical novel) from Pulp Literature Press. He has won the Endeavour and Arthur Ellis Awards and has been shortlisted for the Aurora, Nebula, Philip K. Dick, Endeavour (twice), A.E. Van Vogt, Neffy, and Derringer Awards. He has been inducted into the Canadian Science Fiction and Fantasy Association's Hall of Fame. Praise for The Emir's Falcon “One peregrine falcon raised in a breeding facility, to be released into the wilds of northern Alberta. Three older teens from different cultures, their lives already mapped out by parental expectations. An impulsive action by one places that falcon at the crux of a potential international incident and brings all to the brink of catastrophe in the wilderness. A fascinating and insightful read.” - Alison Lohans, author of Timefall, Don't Think Twice, and twenty-eight other books for young people and adults “The Emir's Falcon is a rich story that soars with action, drama and detail. It raises important issues of cultural and environmental conflict and still entertains and surprises right to the last sentence.” - Arthur Slade, author of Dust, winner of the Governor General's Award http://matthewhughes.org Gayle M. Smith, author of Thickwood, grew up on a mixed subsistence farm in central Alberta where, as a young child, she developed a love for animals, especially horses, and a love for reading and writing illustrated stories. In 1989, Gayle married a Saskatchewan farmer and settled into rural life to raise three children, numerous crops, purebred and commercial cattle, and horses. In 2011, Gayle was accepted into the 2011 Saskatchewan Writers' Guild Mentorship program, where she wrote the first draft of Thickwood, which then became her master's thesis in 2015, when she graduated from the University of Saskatchewan with a Master of Fine Arts in Writing.Yearly wilderness pack trips in Northern Saskatchewan with her horses inspire her writing. She also rides in the mountains, competes in numerous equestrian events, and owns and operates a horse boarding facility. Gayle's love of the environment, history, and adventure shines in her writing. She daily interacts with her beloved partner, her family, her horses, and her rural home, while contemplating and exploring through her writing the struggle and dilemma of being human. About the book Raised on a ranch in Saskatchewan's rugged Thickwood Hills, where the prairie transitions to forest, Willomena Swift, home from playing for the Rockford Peaches of the All-American Girls Professional Baseball League, finds a precious foal killed by a rogue stallion. The stallion's owner, once Willo's baseball coach, now chairs the committee heading up the new cooperative pasture—a pasture that is set to swallow her family lease, where she grew up, learned to love and understand horses, and dreamed of returning to raise them. Facing numerous challenges with both the stallion and his owner, Willo remembers her past years playing professional baseball as she struggles to realize her dreams in the present. Amid romance and tragedy, Willo must find a way to stand on her own and assert her rightful place in her beloved Thickwood. The Douglas Coleman Show now offers audio and video promotional packages for music artists as well as video promotional packages for authors. We also offer advertising. Please see our website for complete details. http://douglascolemanshow.com If you have a comment about this episode or any other, please click the link below. https://ratethispodcast.com/douglascolemanshow

Overview The Emir's Falcon, an exciting new young adult tale of outdoor adventure by award-winning Canadian author Matt (Matthew) Hughes, is now available in print, ebook, and audiobook editions from Saskatchewan publisher Shadowpaw Press Premiere.“The novella evolved out of a real event that happened when I was an aide to Canada's Minister of the Environment,” Matt Hughes explains. “The government decided to give a peregrine falcon to a Persian Gulf emir. I wondered how the teenage volunteers who worked with the birds at the breeding facility would react. Almost forty years later, I stopped wondering and made a story out of it.” Matt (Matthew) Hughes writes fantasy, space opera, and crime fiction. He has sold twenty-four novels to publishers large and small in the UK, US, and Canada, as well as nearly 100 works of short fiction to professional markets. His latest novels are A God in Chains (Dying Earth fantasy) from Edge Publishing and What the Wind Brings (magical realism/historical novel) from Pulp Literature Press. He has won the Endeavour and Arthur Ellis Awards and has been shortlisted for the Aurora, Nebula, Philip K. Dick, Endeavour (twice), A.E. Van Vogt, Neffy, and Derringer Awards. He has been inducted into the Canadian Science Fiction and Fantasy Association's Hall of Fame. His Book https://www.amazon.com/Emirs-Falcon-Matt-Hughes-ebook/dp/B0BC4MPGD6?_encoding=UTF8&qid=1668717297&sr=8-1&linkCode=li2&tag=discoveredwordsmiths-20&linkId=41bf8e6aabddb0e0a1defec9fe4e8eeb&language=en_US&ref_=as_li_ss_il Website https://matthewhughes.org Favorites https://www.amazon.com/Jack-Vance-Treasury-ebook/dp/B00H52RRZW?crid=20SPEOLCMN8UN&keywords=jack+vance&qid=1669395899&sprefix=jack+vance%2Caps%2C106&sr=8-4&linkCode=li2&tag=discoveredwordsmiths-20&linkId=5238dd4d700e0b404937fee58966f85b&language=en_US&ref_=as_li_ss_il YouTube https://youtu.be/EdjbaI5V4FI Transcript I'm recording, so we're all good. Matt: Okay. All right. What would you like to know? Matt, what would I like to know? Welcome to Discovered Wordsmith. First thing I'd really like to know is a little bit about you and where you live. Some of the things you like to do besides writing. Okay. I have been a professional writer all my life. I think I got my first paycheck in 1971. Okay. As a reporter covering municipal councils for a daily in, in Vancouver, and I went into weekly papers, was an editor of a couple of small weeklies, and then a guy who just won election as a member of parliament in Canada. Said, would you like to come to Ottawa and Ghost write my column for the local press in the writing? And I eventually said, yes. I tossed the coin after a week of not being able to make up my mind and off I went to Ottawa and I became the MP assistant. And I was writing his column and helping people with their pension problems and immigration problems, all of that stuff that MP's assistants do. Been there about six weeks and he came into the office and said I'm seconding the speech from the throne debate, which is a big deal. It's where at the beginning of a new par. The government sets out its whole agenda and then there's a debate and they always have a couple of maiden mps do the the seconding and the moving and seconding. And they picked him. So I had to write a speech. He said, write me a speech. So I wrote a speech, one draft. He loved it. He went out and gave it, it killed. And next thing I know cause of that speech, he's getting all these request. For come and speak to this group and that group cuz he's a great speaker cuz he is got a great speech writer. And next thing I know I'm being headhunted by minister's offices and I end up a speech writer to the Minister of Justice. Nice. And later on I went to the Minister of Environment and I did four years in Ottawa as a speech writer. And then I came back to Vancouver and I freelanced for corporate speech writing for almost 30 years.

NEW MUSIC ALERT! Introducing some dope new indie artists. TAP IN!

Indiana rapper Still Smokin' talks most influential artists of all time, why he's done with wing stop, new music & more!

The Sundilla Radio Hour for the week of 06/20/2022 featuring: Joy Clark “Good Thing” Single (2022 Joy Clark) 4:53 Justyn Thyme “It's Been a While” Single (2022 Justyn Thyme) 3:39 Kate Wolf “Across the Great Divide” Close to You (1981 Owl Records) 4:19 Barney Bentall “Whiskey Jack (Home)” Cosmic Dreamer (2022 Golden Cage) 3:40 Rod Picott “Frankie Lee” Paper Hearts & Broken Arrows (2022 Rod Picott) 3:04 Ordinary Elephant “The Things He Saw” Before I Go (2017 Ordinary Elephant) 3:17 Jackson Emmer “Little Things” Alpine Coda (2021 Diamond Ranch) 3:27 Austin MacRae “Bats in the Attic” Bats in the Attic (2015 Austin MacRae) 3:48 Neffy “Wait Up” Single (2022 Neffy) 3:11 Sara Hickman “Song for My Father” Equal Scary People (1989 SLEEVELESS) 4:09 Kaia Kater “New Colossus” Grenades (2018 Smithsonian Folkways) 4:26 Lauren.Napier “Mystic Man” Single (Lauren Napier) 3:31 Susan Cattaneo “All Is Quiet” All Is Quiet (2022 Jersey Girl) 3:22

Rapper Chalmaine The God talks growing up in Detroit, being outside all summer, new music and more!

Ishan The Rapper talks being a mad scientist, linking with DJ Kay Slay, new music & more. Tap in!

Check out our exclusive behind the scenes interview with R&B sensation Marzz at House of Blues Dallas

This week the Homie Neffy Raps stop thru to kick it and let us know what she's been up to. She puts us on to Drip Fest, her concert series, her new single Rah Rah, some acting coming up and her radio station all while kicking it as we usually do week to week, enjoy.

Creator Jewels catches up with Neffy during Texas Media Day. Tap in!

Neffy is joined by R&B phenom Chris Jones. Tap in!

Tyra + Tiara talk Dallas tour, working with TDE & more. Tap in!

Neffy talks Texas Media Day, SXSW, new featured artists & more.

Neffy is drop a new single. Talk about her show The Vibe Session and more. Neffy Raps IG: https://www.instagram.com/neffyraps/?... All our streaming links. https://linktr.ee/DjDuss Clash TV. website: www.clsh.tv App Link: https://apps.apple.com/ca/app/clashtv... Partner: http://nakedamoeba.com Dj Duss: https://www.instagram.com/dj_duss/ Bamboo: https://www.instagram.com/bamboo7162/ #liveonthemic #podcast #liveshow

Neffy talks Drip Fest 3, Texas Media Day, Suicide Prevention & more. Tap in!

The Sundilla Radio Hour for the week of 01/03/2022 featuring: Buskin & Batteau & Tom Rush “One Month Crazier” Click: Songs By Neale Eckstein & Friends (2014 Neale Eckstein) 5:02 Heather Sarona “I'll be Lost” Head Above Water (2022 Heather Sarona) 3:22 Andrew McKnight “When My Time Comes” Treasures in My Chest (2020 Andrew McKnight) 3:53 Lauren Balthrop “We Fell” Songs and Strings (Live) (2021 Starlington Songs) 4:15 Sara Routh “Save Me” Heavy Love (2021 Boots & Whiskey Music) 5:01 Scott Cook “Tulsa” Tangle of Souls (2020 Scott Cook) 3:48 Hiroya Tsukamoto “Tears” Solo (2011 H) 3:09 Neffy “Wait Up” Single (2020 Neffy) 3:11 Alastair Moock “Somewhere Elseward Blown” A Life I Never Had (2002 Alastair Moock) 4:12 Yasmin Williams “Sunshowers” Urban Driftwood (2021 SPINSTER) 4:14 Joan Shelley (featuring Glen Dentinger) “Like Butter Loves Bread” Happy Hollerdays 2021 – A Special Benefit Album for Team West Kentucky Tornado Relief Fund 2:38 Trevor Tchir “Iron Mountain” Sun & Moon (2021 Trevor Tchir) 3:45

Neffy talks rap culture, music news, and more. Tap in!

Bob Boilen | October 27, 2021 It felt good to be home, if only for one night: home, in this case, being my Tiny Desk at NPR. We were about to film Neffy, our 2021 Tiny Desk Contest winner, at my desk at NPR headquarters. My corner of the NPR Music department looked just as I had left it almost 600 days ago; it's eerie inside and nearly nightfall outside. There's no audience for this Sunday evening concert, just our five-person Tiny Desk crew. We had filmed almost 1,000 Tiny Desk concerts before we abandoned the office in mid-March of 2020. What was then exciting yet routine now felt somewhat like a hallucination. For Neffy, it too was a dream: — a dream come true. Her joy during the recording was contagious. Neffy is Mecca Russell, a young singer who grew up around Arlington, Va., just across the river from NPR. Her Contest-winning song "Wait Up" is about living in New York, most recently during the COVID-19 outbreak, but yearning for home. In fact, Neffy did return to her childhood home, where she recorded her winning song with just her heartfelt voice and her guitar. "I wrote 'Wait Up' like many other songs I've written: sitting on the edge of my bed. But I didn't know it would be the song that would change my life," Neffy told us. "I got to sing lyrics I wrote in the privacy of my room late at night to a vast and loving audience is beyond my wildest dreams. For that, I am incredibly grateful, and quite frankly, still in disbelief." We hear three more songs from Neffy during her Tiny Desk concert. It's a small window into an outstanding talent, and we're so proud to share this extraordinary moment.   SET LIST "Like You Did" "Wait Up" "What If" "Hangin' On Too Long"   MUSICIANS Neffy: vocals, guitar   TINY DESK TEAM Producers: Bob Boilen, Kara Frame, Elle Mannion Audio Engineer: Josh Rogosin Videographers: Kara Frame, Maia Stern Editor: Maia Stern Tiny Contest Team: Jessica Goldstein, Marissa Lorusso Tiny Production Team: Bobby Carter, Sofie Hernandez-Simeonidis Creative Director: Bob Boilen Executive Producer: Keith Jenkins Senior VP, Programming: Anya Grundmann #nprmusic #tinydesk #neffy   Team UNPLUGGED.

Some people are born great and some people have greatness thrust upon them.  Neffy Raps is a born EMPRESS ( [ em-pris ], female ruler of an EMPIRE.  The voice of Neffy Raps is unparalleled and the movement is ultra disruptive.  "Hey Siri, play the BETONYOURSELF Podcast" Support this podcast at — https://redcircle.com/betonyourself/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy